Clinical Research
Copyright ©The Author(s) 2003.
World J Gastroenterol. Dec 15, 2003; 9(12): 2809-2812
Published online Dec 15, 2003. doi: 10.3748/wjg.v9.i12.2809
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Cumulative disease-free survival for patients with CD117-positive GIST based on tumor size.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Cumulative disease-free survival for patients with CD117-positive GIST based on mitotic count.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Cumulative survival for patients with CD117-posi-tive GIST based on tumor size.
Figure 4
Open in New Tab Full Size Figure Download Figure
Figure 4 Cumulative survival for patients with CD117-posi-tive GIST based on mitotic count.
Figure 5
Open in New Tab Full Size Figure Download Figure
Figure 5 Cumulative survival for patients with CD117-posi-tive GIST based on resectability.
Figure 6
Open in New Tab Full Size Figure Download Figure
Figure 6 Cumulative disease-free survival for patients with CD117-positive GIST based on risk of aggressive behaviors.